Research ExplorerPublicationsOutcome of uterine artery embolization versus MR-guided high...

Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results

Standard

Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. / Froeling, V; Meckelburg, K; Schreiter, N F; Scheurig-Muenkler, C; Kamp, J; Maurer, M H; Beck, A; Hamm, B; Kroencke, T J.

In: EUR J RADIOL, Vol. 82, No. 12, 12.2013, p. 2265-9.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Froeling, V, Meckelburg, K, Schreiter, NF, Scheurig-Muenkler, C, Kamp, J, Maurer, MH, Beck, A, Hamm, B & Kroencke, TJ 2013, 'Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results', EUR J RADIOL, vol. 82, no. 12, pp. 2265-9. https://doi.org/10.1016/j.ejrad.2013.08.045

APA

Froeling, V., Meckelburg, K., Schreiter, N. F., Scheurig-Muenkler, C., Kamp, J., Maurer, M. H., Beck, A., Hamm, B., & Kroencke, T. J. (2013). Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. EUR J RADIOL, 82(12), 2265-9. https://doi.org/10.1016/j.ejrad.2013.08.045

Vancouver

Froeling V, Meckelburg K, Schreiter NF, Scheurig-Muenkler C, Kamp J, Maurer MH et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. EUR J RADIOL. 2013 Dec;82(12):2265-9. https://doi.org/10.1016/j.ejrad.2013.08.045

Bibtex

@article{d190a936f5dc4944b4ee6cfff86499b0,
title = "Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results",
abstract = "OBJECTIVES: To compare the long-term outcome after uterine artery embolization (UAE) versus magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids.METHODS: Seventy-seven women (median age, 39.3 years; range, 29.2-52.2 years) with symptomatic uterine fibroids, equally eligible for UAE and MR-g HIFU based on our exclusion criteria underwent treatment (UAE, N = 41; MR-g HIFU, N = 36) from 2002 to 2009 at our institution. Symptom severity (SS) and total health-related quality of life (Total HRQoL) scores were assessed by the uterine fibroid symptom and quality of life (UFS-QoL) questionnaire before treatment and at long-term follow-up after UAE (median 61.9 months) and after MR-g HIFU (median: 60.7 months). Re-intervention rates were assessed for each therapy and compared.RESULTS: Re-intervention was significantly lower after UAE (12.2%) than after MR-g HIFU (66.7%) at long-term follow-up (p<0.001). After UAE changes in SS (50 pre-treatment vs. 6.3 post-treatment) and Total HRQoL (57.8 pre-treatment vs. 100 post-treatment) were significantly better than changes in SS (42.2 pre-treatment vs. 26.6 post-treatment) and Total HRQoL score (66.4 pre-treatment vs. 87.9 post-treatment) after MR-g HIFU (p = 0.019 and 0.049 respectively).CONCLUSIONS: Improvement of SS and Total HRQoL scores was significantly better after UAE resulting in a significant lower re-intervention rate compared to MR-g HIFU.",
keywords = "Adult, Female, High-Intensity Focused Ultrasound Ablation/methods, Humans, Leiomyoma/pathology, Longitudinal Studies, Magnetic Resonance Imaging/methods, Middle Aged, Surgery, Computer-Assisted/methods, Treatment Outcome, Uterine Artery Embolization/methods, Uterine Neoplasms/pathology",
author = "V Froeling and K Meckelburg and Schreiter, {N F} and C Scheurig-Muenkler and J Kamp and Maurer, {M H} and A Beck and B Hamm and Kroencke, {T J}",
note = "Copyright {\textcopyright} 2013. Published by Elsevier Ireland Ltd.",
year = "2013",
month = dec,
doi = "10.1016/j.ejrad.2013.08.045",
language = "English",
volume = "82",
pages = "2265--9",
journal = "EUR J RADIOL",
issn = "0720-048X",
publisher = "Elsevier",
number = "12",

}

RIS

TY - JOUR

T1 - Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results

AU - Froeling, V

AU - Meckelburg, K

AU - Schreiter, N F

AU - Scheurig-Muenkler, C

AU - Kamp, J

AU - Maurer, M H

AU - Beck, A

AU - Hamm, B

AU - Kroencke, T J

N1 - Copyright © 2013. Published by Elsevier Ireland Ltd.

PY - 2013/12

Y1 - 2013/12

N2 - OBJECTIVES: To compare the long-term outcome after uterine artery embolization (UAE) versus magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids.METHODS: Seventy-seven women (median age, 39.3 years; range, 29.2-52.2 years) with symptomatic uterine fibroids, equally eligible for UAE and MR-g HIFU based on our exclusion criteria underwent treatment (UAE, N = 41; MR-g HIFU, N = 36) from 2002 to 2009 at our institution. Symptom severity (SS) and total health-related quality of life (Total HRQoL) scores were assessed by the uterine fibroid symptom and quality of life (UFS-QoL) questionnaire before treatment and at long-term follow-up after UAE (median 61.9 months) and after MR-g HIFU (median: 60.7 months). Re-intervention rates were assessed for each therapy and compared.RESULTS: Re-intervention was significantly lower after UAE (12.2%) than after MR-g HIFU (66.7%) at long-term follow-up (p<0.001). After UAE changes in SS (50 pre-treatment vs. 6.3 post-treatment) and Total HRQoL (57.8 pre-treatment vs. 100 post-treatment) were significantly better than changes in SS (42.2 pre-treatment vs. 26.6 post-treatment) and Total HRQoL score (66.4 pre-treatment vs. 87.9 post-treatment) after MR-g HIFU (p = 0.019 and 0.049 respectively).CONCLUSIONS: Improvement of SS and Total HRQoL scores was significantly better after UAE resulting in a significant lower re-intervention rate compared to MR-g HIFU.

AB - OBJECTIVES: To compare the long-term outcome after uterine artery embolization (UAE) versus magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids.METHODS: Seventy-seven women (median age, 39.3 years; range, 29.2-52.2 years) with symptomatic uterine fibroids, equally eligible for UAE and MR-g HIFU based on our exclusion criteria underwent treatment (UAE, N = 41; MR-g HIFU, N = 36) from 2002 to 2009 at our institution. Symptom severity (SS) and total health-related quality of life (Total HRQoL) scores were assessed by the uterine fibroid symptom and quality of life (UFS-QoL) questionnaire before treatment and at long-term follow-up after UAE (median 61.9 months) and after MR-g HIFU (median: 60.7 months). Re-intervention rates were assessed for each therapy and compared.RESULTS: Re-intervention was significantly lower after UAE (12.2%) than after MR-g HIFU (66.7%) at long-term follow-up (p<0.001). After UAE changes in SS (50 pre-treatment vs. 6.3 post-treatment) and Total HRQoL (57.8 pre-treatment vs. 100 post-treatment) were significantly better than changes in SS (42.2 pre-treatment vs. 26.6 post-treatment) and Total HRQoL score (66.4 pre-treatment vs. 87.9 post-treatment) after MR-g HIFU (p = 0.019 and 0.049 respectively).CONCLUSIONS: Improvement of SS and Total HRQoL scores was significantly better after UAE resulting in a significant lower re-intervention rate compared to MR-g HIFU.

KW - Adult

KW - Female

KW - High-Intensity Focused Ultrasound Ablation/methods

KW - Humans

KW - Leiomyoma/pathology

KW - Longitudinal Studies

KW - Magnetic Resonance Imaging/methods

KW - Middle Aged

KW - Surgery, Computer-Assisted/methods

KW - Treatment Outcome

KW - Uterine Artery Embolization/methods

KW - Uterine Neoplasms/pathology

U2 - 10.1016/j.ejrad.2013.08.045

DO - 10.1016/j.ejrad.2013.08.045

M3 - SCORING: Journal article

C2 - 24075785

VL - 82

SP - 2265

EP - 2269

JO - EUR J RADIOL

JF - EUR J RADIOL

SN - 0720-048X

IS - 12

ER -